Tag:
Venus Pharmaceuticals
Latest Headlines
Latest Headlines
Venus warning letter belies poor 483 response
A belief in FDA rubber-stamping any company response to inspection findings is perhaps the most likely explanation behind the warning letter to a dietary supplement maker. The letter, posted recently
